Jeff, I agree that at some point they appear to have switched gears from HSDD to CV event reduction. Most likely when they removed the stable dose of estrogen requirement mid trial.
In any event I believe the deal announcement will soon be on us.
Normally you can see ANIPp advertising their employment opportunities on websites like Indeed, Monster and Linkedin. Now they are down to only three position only on their own website. None of the other sites.
BPAX experienced something similar prior to announcing the proposed merger with ANIP. The position were modified to look for local people only.
News 
Market Data 
Discover 
